MedTech News
.................... by Andrew Celentano

Stryker introduces FDA-cleared surgical application for Apple Vision Pro
Stryker (NYSE: SYK) has announced the first clinical use of SportsSuite Vision using the mixed-reality Apple Vision Pro.

Small spaces and stiffness may help cancer cells escape and spread
A new biomaterial developed by researchers from The University of Western Australia is providing fresh insights into the way cancer cells escape from tumors and spread through the body.

New class of KRAS inhibitors shows promise in shrinking NF1 nerve tumors
A scientist at Cincinnati Children’s who has hunted for decades for ways to shrink the painful and disfiguring nerve tumors caused by neurofibromatosis type 1 (NF1) has made a new breakthrough in the quest.

Tau’s surprise birthplace offers a clue to how Alzheimer’s tangles begin
Where and how does an Alzheimer’s tangle begin? A new study by neuroscientists at Columbia University challenges a long-held assumption about the source of toxic tau proteins, which form neurofibrillary tangles and are closely linked to memory decline in Alzheimer’s disease.

Mini-tumors reveal new drug combinations for liver cancer
Liver cancer is difficult to treat because tumors vary greatly from patient to patient. Researchers at the University of Basel have captured this diversity by creating a collection of mini-tumors, which they use to systematically search for new treatment options. They tested more than 1,600 compounds using these organoids and used the results to develop promising drug combinations.

Lab-grown tissue reveals how inflammation may drive heart relaxation failure
Lab-grown tissues engineered from stem cells reprogrammed from human cells, called human induced pluripotent stem cells (hiPSCs), are rapidly emerging as a more reliable and accessible model in medical research.

ECG-based AI algorithm could improve detection and prediction of heart diseases
Now, scientists at Scripps Research have built a new AI model to improve detection and prediction of various heart diseases, which may be particularly useful in settings with limited labeled data or fewer available ECG leads

Blocking a microRNA reverses deadly lung disease in multiple models
Researchers blocked a naturally occurring molecule to reverse pulmonary arterial hypertension in preclinical models, a finding that could point to a new treatment approach for people with a rare and often fatal lung disease.